Cargando…

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries

Ovarian clear cell carcinoma (OCCC) is a rare but chemorefractory tumor. About 50% of all OCCC patients have inactivating mutations of ARID1A, a member of the SWI/SNF chromatin-remodeling complex. Members of the SWI/SNF remodeling have emerged as regulators of the energetic metabolism of mammalian c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaonan, Shetty, Mihir, Clemente, Valentino, Linder, Stig, Bazzaro, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124918/ https://www.ncbi.nlm.nih.gov/pubmed/33947138 http://dx.doi.org/10.3390/ijms22094750

Ejemplares similares

Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers
por: Zhang, Xiaonan, et al.
Publicado: (2020)

Dienone Compounds: Targets and Pharmacological Responses
por: Bazzaro, Martina, et al.
Publicado: (2020)

GLS1 is a Protective Factor in Patients with Ovarian Clear Cell Carcinoma and its Expression Does Not Correlate with ARID1A-mutated Tumors
por: Clemente, Valentino, et al.
Publicado: (2022)

The microtubule-severing protein UNC-45A preferentially binds to curved microtubules and counteracts the microtubule-straightening effects of Taxol
por: Hoshino, Asumi, et al.
Publicado: (2023)

UNC-45A Is Highly Expressed in the Proliferative Cells of the Mouse Genital Tract and in the Microtubule-Rich Areas of the Mouse Nervous System
por: Clemente, Valentino, et al.
Publicado: (2021)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
por: Emmings, Edith, et al.
Publicado: (2019)

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
por: Clemente, Valentino, et al.
Publicado: (2020)

UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTs
por: Habicht, Juri, et al.
Publicado: (2019)

Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors
por: Zhang, Xiaonan, et al.
Publicado: (2015)

Clear-Cell Carcinoma of the Ovary with Bilateral Breast Metastases
por: Galili, Yehuda, et al.
Publicado: (2019)

Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review)
por: UEKURI, CHIHARU, et al.
Publicado: (2013)

Ruptured clear cell carcinoma of the ovary presenting as acute abdomen
por: Zhou, Zhen Ni, et al.
Publicado: (2016)

Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary
por: Mori, Hidemi, et al.
Publicado: (2023)

Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments
por: Zhang, Xiaonan, et al.
Publicado: (2014)

Borderline Clear Cell Adenofibroma of the Ovary
por: Kleebkaow, Pilaiwan, et al.
Publicado: (2017)

Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?
por: Takano, Masashi, et al.
Publicado: (2012)

Clear cell carcinoma of the ovary: multi-slice computed tomography findings
por: Li, Xubin, et al.
Publicado: (2015)

Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
por: Mabuchi, Seiji, et al.
Publicado: (2016)

Sensitivity to Anticancer Agents and Resistance Mechanisms in Clear Cell Carcinoma of the Ovary
por: Itamochi, Hiroaki, et al.
Publicado: (2002)

Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
por: Morioka, Sachiko, et al.
Publicado: (2019)

Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models
por: Rupert, Christofer, et al.
Publicado: (2023)

Clear cell carcinoma of ovary with squamous metaplasia: A unique histopathological observation
por: Das, Prasenjit, et al.
Publicado: (2011)

Clear cell carcinoma of the ovary: Clinicopathologic features and outcomes in a Chinese cohort
por: Tang, Haosha, et al.
Publicado: (2018)

MYC is downregulated by a mitochondrial checkpoint mechanism
por: Zhang, Xiaonan, et al.
Publicado: (2017)

SR-B1 and CD10 combined immunoprofile for differential diagnosis of metastatic clear cell renal cell carcinoma and clear cell carcinoma of the ovary
por: Jiang, Teng, et al.
Publicado: (2021)

Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment
por: Zhang, Xiaonan, et al.
Publicado: (2019)

Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma
por: Yamaguchi, Ken, et al.
Publicado: (2021)

Development and validation of a mitochondrial metabolism‐associated nomogram for prediction of prognosis in clear cell renal cell carcinoma
por: Zeng, Bohan, et al.
Publicado: (2020)

A Three-Metabolic-Genes Risk Score Model Predicts Overall Survival in Clear Cell Renal Cell Carcinoma Patients
por: Zhao, Yiqiao, et al.
Publicado: (2020)

Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma
por: Nishida, K., et al.
Publicado: (2016)

Endometriosis in clear cell and endometrioid carcinoma ovary: its impact on clinicopathological characteristics and survival outcomes
por: Kundur, Mythili, et al.
Publicado: (2023)

Clear Cell Borderline Tumor of the Ovary: A Case Report
Publicado: (2023)

Metabolic reprogramming of clear cell renal cell carcinoma
por: Zhu, Haiyan, et al.
Publicado: (2023)

In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma
por: Kaushik, Akash K., et al.
Publicado: (2022)

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
por: Takano, M, et al.
Publicado: (2006)

Mural Nodules of Clear Cell Carcinoma in a Mucinous Borderline Tumor of the Ovary: A Case Report
por: Allende, Daniela S., et al.
Publicado: (2010)

X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary
por: Miyamoto, M, et al.
Publicado: (2014)

Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes
por: Hsu, Yueh-Han, et al.
Publicado: (2020)

The target therapy of ovarian clear cell carcinoma
por: Jin, Ying, et al.
Publicado: (2014)

Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control
por: Lundqvist, Andreas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9nvdp4c28ac3dj99o1k3gic6pg